Lecheng’s 25 medical-travel routes feature a Canadian group’s surgery and check-ups
A July 2025 report follows actual overseas visitors and describes the zone’s treatment, rehabilitation, health-management and cultural travel services.
Published by CareAtlas · Editorial policy
Boao Lecheng International Medical Tourism Pilot Zone had launched 25 themed medical-travel routes, according to a July 5, 2025 report published on the State Council’s English website. The article follows a Canadian group visiting the Hainan zone, including one traveler who underwent surgery and others who received health check-ups.
Surgery during a four-day visit
Canadian figure-skating coach Mark Batka had growing lumps on his chest and back that interfered with his work. During a four-day wellness trip to Lecheng, he chose to have surgery. He said arranging the procedure in Canada would have taken time and cost more, and expressed satisfaction with his experience in China. Those comments describe his own visit, rather than a published price or waiting-time comparison.
The report does not give a pathology diagnosis or long-term result.
Check-ups, recovery and cultural activities
Other Canadian group members described their time at Boao Yiling Life Care Center. Janet Wong said the health check-up was thorough. Stephanie Wing See Yau welcomed the range of services in one place and the attention to mental as well as physical well-being.
The center’s stated services include health management, disease prevention, specialized treatment, rehabilitation and mental wellness. Cultural activities such as incense appreciation, tea ceremonies and calligraphy were also part of the reported travel experience.
The zone’s 25 routes cover different themes, including traditional Chinese medicine, chronic disease management, diagnostic examinations and cosmetic rehabilitation.
Special-policy medicines and the scale of services
At the time, Lecheng had more than 30 medical institutions. Under its special policy arrangements, it had introduced 485 medicines and medical devices approved overseas but not yet available on the domestic market. More than 130,000 patients had benefited, according to the report. Those figures refer to the zone’s offering in July 2025.
In 2024, total medical visits exceeded 410,000, an increase of 36.76% over the previous year. This total is not an overseas-patient count. The zone also reported partnerships with more than 180 pharmaceutical and device companies from 20 countries.
He Ying, an official in the zone’s medical-tourism department, said further work would strengthen service platforms and international reception capabilities.